newsfilter
← Latest News
GlobeNewswire·

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

WAYNE, Pa. and ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that